Type 1 diabetes immunological tolerance and immunotherapy

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Chentoufi, Aziz Alami ^a   Geenen, Vincent ^b   Giannokakis, Nick ^c   Amrani, Abdelaziz ^d  

^a Pathology Clinical Laboratory Medicine   (Saudi Arabia)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXP3; UBIQUITIN PROTEIN LIGASE E3;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; EDITORIAL; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; HUMAN; IMMUNOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY;

EID: 84855612935     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/103738     Document Type: Editorial

References (0)